Observational Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Oct 14, 2023; 29(38): 5395-5405
Published online Oct 14, 2023. doi: 10.3748/wjg.v29.i38.5395
Figure 1
Figure 1 Constituent ratio of age among three infection groups’ patients and the hepatitis D virus screening positive rate of hepatitis B patients with different age. A and B: Age was compared using Kruskal-Wallis test, error bars represent 95% confidence interval. Note: The screening positive rate of hepatitis D virus in patients who were 30 years old or younger, and who were over 80 years old were 0.0%, and not shown in figure 1B. HDAg: Hepatitis D antigen; HDV: Hepatitis D virus.
Figure 2
Figure 2 Constituent ratio of hepatitis B surface antigen among three infection groups’ patients and the hepatitis D virus screening positive rate of hepatitis B patients with different hepatitis B surface antigen. A and B: Hepatitis B surface antigen (HBsAg) was compared using Kruskal-Wallis test, error bars represent 95% confidence interval. HBsAg: Hepatitis B surface antigen; HDAg: Hepatitis D antigen; HDV: Hepatitis D virus.
Figure 3
Figure 3 Constituent ratio of hepatitis B virus DNA among three infection groups’ patients and the hepatitis D virus screening positive rate of hepatitis B patients with different hepatitis B virus DNA. A and B: Hepatitis B virus DNA was compared using Kruskal-Wallis test, error bars represent 95% confidence interval. HBV: Hepatitis B virus; HDV: Hepatitis D virus.
Figure 4
Figure 4 Distribution of anti-hepatitis D antigen among two infection groups’ patients and hepatitis D virus RNA positive rate of patients with different anti-HDAg. A and B: Anti-hepatitis D antigen was compared using Mann-Whitney U test, error bars represent 95% confidence interval. HDAg: Hepatitis D antigen; HDV: Hepatitis D virus.
Figure 5
Figure 5 Distribution of the hepatitis D virus RNA among hepatitis B virus-hepatitis D virus dual-infected patients. HDV: Hepatitis D virus.